Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinqiao Xiashi Formula or Xuanling Yinhuang Formula plus Angong Niuhuang Bolus for adult viral encephalitis and meningitis
ChiCTR1900023279Phase 4Not yet recruiting
- Sponsor
- Beijing Ditan Hospital
- Start
- Jan 2017
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Yin Qiao San, Xuanling Yinhuang Formula and An'gong Niuhuang Pill in viral encephalitis and viral meningitis (VM) (2 arms), sponsored by Beijing Ditan Hospital. Primary endpoint: Cure rate. Planned start Jan 2017; status: not yet recruiting.
02
Drugs
Yin Qiao SanXuanling Yinhuang FormulaAn'gong Niuhuang Pill
03
Conditions
viral encephalitisviral meningitis (VM)
Beyond the preview
Go deeper on ChiCTR1900023279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023279.